DBV Technologies S.A. - American Depositary Shares (DBVT) Covered Calls

DBV Technologies SA is an epicutaneous immunotherapy company. The Company is engaged in research and development of patient-friendly therapy for food and pediatric allergy patients.

There are no covered calls available for DBV Technologies S.A. - American Depositary Shares.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

DBV Technologies SA is a clinical-stage biopharmaceutical specialty company, which focuses on developing a novel technology platform called Viaskin. Viaskin is an electrostatic patch, which offers a convenient, self-administered, non-invasive immunotherapy to patients. It has designed two products candidates: Viaskin Peanut and Viaskin Milk. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Bagneux, France.